01 Communique Reports Third Quarter Fiscal 2016 Results and Announces a Change in Auditors

TORONTO, Sept. 12, 2016 /CNW/ - 01 Communique Laboratory Inc. (ONE:TSX-V) today announced results for its third quarter fiscal 2016, which ended July 31, 2016. The loss and comprehensive loss for the third quarter was $162,660 (2015 - $345,956). The adjusted loss, which excludes non-cash expenses for stock-based compensation and depreciation, was $70,206 (2015 - $297,216). The Company completed the period with $211,172 of cash and cash equivalents.   

"We remain committed to our plan of continuing operations as well as pursuing the matter with Citrix Systems Inc. ("Citrix") until its conclusion," said Andrew Cheung, President and CEO for 01 Communique. "Earlier in the year we significantly reduced operating expenses to conserve our cash as we work through this process. With respect to the lawsuit with Citrix, all briefs with respect to post-trial motions were filed in April 2016. We are now waiting for a decision by the District Court and then an appeal to the United States Court of Appeals for the Federal Circuit can be taken, if needed. The motions included motions for renewed judgment as a matter of law and for a new trial."  

An Update on the Company's Operations follows:

At the request of the Company, KPMG LLP has resigned as the Company's auditors. The Company has appointed Shimmerman Penn LLP to replace them. The board of directors of the Company and its audit committee has approved the resignation of KPMG LLP and the appointment of Shimmerman Penn LLP.

In addition to moving forward with the appeal process in its patent lawsuit against Citrix the Company plans to continue and work with Hitachi as well as approach other companies with a goal for them to license the Company's products and technology. Substantially all development work has been completed on the products that the Company is looking to license and with respect to the appeal process the Company relies on its lawyers and hence minimal internal resources are expected. Accordingly, the Company has reduced operating expenses significantly as it works through the appeal process. To assist in achieving this expense reduction the Company's executive management and board of directors are not drawing a salary.

Operating expenses for third quarter 2016 were $158,438 (2015 - $356,229). Excluding non cash expenses for stock based compensation and depreciation the cash operating expenses for third quarter 2016 were $65,984 (2015 - $307,489) a reduction of $241,505.

On September 12, 2016 stock options were granted to members of the Company's executive management and directors. There were 2,150,000 stock options granted in total expiring on September 12, 2020, with an exercise price of $0.05 and vesting on March 12, 2017.   

Background on the Company's patent lawsuit against Citrix:

In February 2006, the Company commenced a lawsuit in the United States District Court, Northern District of Ohio, Eastern Division, against Citrix alleging infringement by their GoToMyPC product line of the '479 Patent. On January 11, 2016 a jury trial commenced in the lawsuit with the jury reaching and returning a unanimous verdict on January 19, 2016. The Court entered Judgment as follows:

  1. Defendants Citrix have not infringed claims 24 or 45 of 01 Communique's patent (United States Patent No. 6,928,479);

  2. Claims 24 and 45 of United States Patent No. 6,928,479 are not invalid;

  3. Plaintiff 01 Communique takes no damages from Citrix;

  4. Except as set forth above or adjudicated through Summary Judgment, all other claims and counterclaims in this matter were dismissed;

  5. Each party retains its right to, and does not waive its right to, file timely motions for renewed judgment as a matter of law, for new trial, for the award of attorneys' fees, for the award of costs, and to prosecute an appeal from any aspect of the case to the extent allowed by statute, the Federal Rules of Civil Procedure, and/or this Court.

On March 7, 2016 the Company filed post-trial motions with the District Court that presided over the trial. These included motions for renewed judgment as a matter of law and for a new trial. Citrix's opposition brief to these motions was filed and the Company's reply brief was filed on April 28, 2016. Now that all briefs are filed we are waiting for a decision by the District Court on this matter and then an appeal to the United States Court of Appeals for the Federal Circuit can be taken, if needed.

Neither TSX Venture Exchange ("TSX-V") nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About 01 Communique
Established in 1992, 01 Communique Laboratory Inc. (TSX-V:ONE) offers a suite of remote access services designed for small-medium sized business, mobile professionals and IT service providers. 01's software as a service offerings are deployed on-demand and include functionality enabling on-line meetings, remote computing and IT support. 01's suite of products includes its remote access offering I'm InTouch (www.imintouch.com), its online meeting offering (www.imintouchmeeting.com) and its remote support offering I'm OnCall (www.imoncall.com) products are protected in the U.S.A. by its patents #6,928,479 / #6,938,076 / #8,234,701 and in Canada by its patents #2,309,398 / #2,524,039 and Japan by its patent #4,875,094. For more information, visit www.01com.com or call (905) 795-888 or (800) 668-2185 (North America only).

Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "plan", "intend", "are confident" and other similar terminology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release.  Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved.  A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk Factors" in the company's Annual Information Form filed on SEDAR. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the company cannot assure investors that actual results will be consistent with these forward looking statements. These forward-looking statements are made as of the date of this news release, and the company assumes no obligation to update or revise them to reflect new events or circumstances.


01 Communique Laboratory Inc.

SELECTED FINANCIAL INFORMATION

Consolidated Statements of Financial Position

Unaudited





31-July-16

31-Oct-15




Assets



Current assets




Cash and cash equivalents

$

211,172

$

551,205


Accounts receivable

26,748

112,034


Prepaid expenses and other assets

60,299

21,618


298,219

684,857




Property and equipment

5,169

8,596


$

303,388

$

693,453




Liabilities and Shareholders' Equity






Current liabilities




Accounts payable and accrued liabilities

$

492,175

$

549,499


Deferred revenue

13,705

15,081


505,880

564,580




Liability portion of Debenture

370,580

359,714


876,460

924,294

Shareholders' equity




Share capital

40,832,777

40,628,777


Equity portion of Debenture

47,111

47,111


Contributed surplus

5,324,937

5,036,997


Deficit

(46,777,897)

(45,943,726)


(573,072)

(230,841)


$

303,388

$

693,453

 

 

01 Communique Laboratory Inc.

SELECTED FINANCIAL INFORMATION

 Consolidated Statements of Operations and Comprehensive Income

 For the 3 and 9 month periods ended July 31, 2016 and 2015

Unaudited






for the 3 months ending


for the 9 months ending


31-Jul-16

31-Jul-15


31-Jul-16

31-Jul-15







 Revenue

$

9,453

$

23,018


$

56,456

$

76,311

 Cost of revenue

-

-


-

-


9,453

23,018


56,456

76,311







Expenses (income) :






Selling, general and administrative

130,594

162,032


583,682

575,728

Patent litigation & re-examination expenses

-

-


-

6,658

Research and development

27,844

194,197


266,923

590,352

Interest

(81)

(497)


(844)

(1,911)


158,357

355,732


849,761

1,170,827

Loss before interest and accretion on 






liability component of debenture

$

(148,904)

$

(332,714)


$

(793,305)

$

(1,094,516)







Interest on debenture

10,000

10,000


30,000

10,650

Accretion on liability portion of debenture

3,756

3,242


10,866

3,462







Loss for the period and comprehensive loss

$

(162,660)

$

(345,956)


$

(834,171)

$

(1,108,628)



















Loss per common share  (note 6)






Basic

$

(0.002)

$

(0.005)


$

(0.013)

$

(0.017)

Diluted

$

(0.002)

$

(0.005)


$

(0.013)

$

(0.017)







Weighted average number of common shares 

Basic

66,543,807

65,795,437


66,468,807

65,761,159

Diluted

66,543,807

65,795,437


66,468,807

65,761,159

 

 

01 Communique Laboratory Inc.

SELECTED FINANCIAL INFORMATION

Consolidated Statements of Cash Flows

For the 3 and 9 month periods ended July 31, 2016 and 2015








three months

ending


nine months

ending


31-Jul-16

31-Jul-15


31-Jul-16

31-Jul-15

Cash provided by (used in):












Operating activities:







Loss for the period

$

(162,660)

$

(345,956)


$

(834,171)

$

(1,108,628)


Adjustments to reconcile loss for the







period to net cash flows from operating activities








Depreciation

1,204

1,392


4,080

4,719



Stock-based compensation

91,250

47,348


368,940

165,418



Accretion on liability portion of debenture

3,756

3,242


10,866

3,462



Interest paid on debenture

10,000



30,000




Interest income

(81)

(497)


(844)

(1,911)


Change in non-cash working capital

10,619

7,708


(12,094)

(197,589)


(45,912)

(286,763)


(433,223)

(1,134,529)

Interest income received

81

497


844

1,911


(45,831)

(286,266)


(432,379)

(1,132,618)







Financing activities:







Issue of common shares

-

205,000


123,000

205,000


Issue of debenture

-

-


-

400,000


Interest paid on debenture

(10,000)



(30,000)


Investing activities:







Purchase of capital assets

-

(1,017)


(655)

(1,758)

Increase (decrease) in cash

(55,831)

(82,283)


(340,034)

(529,376)







Cash and cash equivalents, beginning of period

267,003

923,720


551,205

1,370,813

Cash and cash equivalents, end of period

$

211,172

$

841,437


$

211,171

$

841,437













Cash and cash equivalents comprise:






Demand deposits

$

71,500

$

601,500




Cash  

139,672

239,937





$

211,172

$

841,437




 

SOURCE 01 Communique Laboratory Inc.

For further information: INVESTOR CONTACT: Brian Stringer, Chief Financial Officer, 01 Communique, (905) 795-2888 x204, brian.stringer@01com.com

RELATED LINKS
http://www.01com.com

Organization Profile

01 Communique Laboratory Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890